BioPartner Nordic ApS: Financial statements 2020
CVR: 38153188
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
BioPartner Nordic ApS (CVR 38153188) has filed annual accounts for 2020. In 2020, the company reported revenue of DKK 240,490 and a net result of DKK 55,766 compared with DKK -167,368 the year before. That is an increase of 315.9% compared with the year before. The profit margin was 23.2%. Equity in the 2020 report amounted to DKK -62,090.
- Revenue
- DKK 240,490
- Gross Profit
- DKK 78,266
- Profit/Loss
- DKK 55,766
- Equity
- DKK -62,090
- Total Assets
- DKK 216,867
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | 240K | 78K | 56K | -62K | - |
| 2019 | 58K | -137K | -167K | -118K | - |
| 2018 | 587K | 185K | 185K | 50K | - |
Official annual report
How creditworthy is BioPartner Nordic ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
BioPartner Nordic ApS has published its annual report for 2019. Revenue came to DKK 57,824, and the net result was DKK -167,368.
About BioPartner Nordic ApS
BioPartner Nordic ApS is a Danish company of the type Anpartsselskab based in Hedehusene, founded in 2016. The company is registered under the industry Anden teknisk rådgivning. The management consists of John Holger Schultz. The company is owned by John Holger Schultz. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK -7,778 and a net result of DKK -27,378 compared with DKK -79,721 the year before. Equity in the 2025 report amounted to DKK 22,622.
